Condition

Richter Syndrome (2)

Chronic Lymphocytic Leukemia (1)

DLBCL (1)

MYC Amplification (1)

MYC Overexpression (1)

MYC Translocation (1)

Refractory Chronic Lymphocytic Leukemia (1)

Relapsed Non Hodgkin Lymphoma (1)

Overall Status

Recruiting (1)

Terminated (1)

Sign in for free

Phase

phase 1 (1)

phase 1/phase 2 (1)

Sponsor

Acerta Pharma BV (1)

Vincerx Pharma, Inc. (1)

Collaborator

Intervention

acalabrutinib (1)

vip152 (1)

vistusertib (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Industry (2)

Study Type

Interventional (2)

Richter Syndrome

Showing NaN - NaN of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Relapsed Non Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, Refractory Chronic Lymphocytic Leukemia Trial in Poland, United

Recruiting

Relapsed Non Hodgkin Lymphoma
+6 more

VIP152

Cincinnati, Ohio
+4 more

Aug 3, 2022

DLBCL, Richter Syndrome Trial in United Kingdom, United States (acalabrutinib, vistusertib)

Terminated

DLBCL
Richter Syndrome

Fairway, Kansas
+10 more

Jan 4, 2021